Reuters logo
BRIEF-Roche gets EU approval of Venclyxto for hard-to-treat form of leukaemia
December 8, 2016 / 6:18 AM / 9 months ago

BRIEF-Roche gets EU approval of Venclyxto for hard-to-treat form of leukaemia

Dec 8 (Reuters) - Roche Holding Ag

* Says roche announces european approval of venclyxto for people with hard-to-treat chronic lymphocytic leukaemia Further company coverage: (Reporting By Zurich newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below